Delivery Order SPE2DB24D2205-SPE2DB26FDSUJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Multaq 400 mg tablets (60-count packages) valued at $11,622.61. This competitively awarded, firm fixed-price delivery order is set to be completed by October 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $24,960.51 with firm fixed pricing. This competitively awarded, non-set-aside contract is scheduled for completion by September 15, 2025, with performance of work occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,697.14 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Multaq 400 mg tablets (60-count units). The contract, which is a non-set-aside competitive award, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. Performance will take place at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Multaq 400 mg tablets (60-count) with a ceiling value of $1,920.12. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 23, 2025. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Multaq 400 mg tablets (60-count units) under a firm fixed-price contract. The order, valued at $3,116.42, is scheduled for completion by October 24, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This award represents a non-competed delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $11,602.70. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on April 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under the vendor's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $8,201.13. This firm fixed-price delivery order, which is scheduled for completion by August 19, 2025, represents a competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) valued at $3,359.77, with an ultimate completion date of September 11, 2025. This competitive award, issued September 10, 2025, utilizes firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a $10.7K delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Multaq 400 mg tablets (60-count units). The award is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and a completion deadline of September 17, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $6,845.09 under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order is scheduled for completion by June 3, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB26FDSUJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Multaq 400 mg tablets (60-count units) under a firm fixed-price contract. The order, valued at $7,425.05, is scheduled for completion by October 28, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems through its comprehensive IDC vehicle. The parent contract enables the company to supply a wide range of pharmaceutical products and medical supplies globally, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Multaq—a cardiac arrhythmia medication—exemplifies the company's role in providing brand-name pharmaceuticals across multiple therapeutic domains to support military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 10/27/25 |